€3.36
9.80% today
Xetra, Nov 26, 03:05 pm CET
ISIN
DE0005495626
Symbol
GME
Sector

Geratherm Medical Target price 2024 - Analyst rating & recommendation

Geratherm Medical Classifications & Recommendation:

Buy
100%

Geratherm Medical Price Target

Target Price €7.00
Price €3.06
Potential
Number of Estimates 1
1 Analyst has issued a Geratherm Medical price target 2025. The average Geratherm Medical target price is €7.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Geratherm Medical to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Geratherm Medical stock has an average upside potential 2025 of . Most analysts recommend the Geratherm Medical stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million € 20.96 17.80
18.92% 15.08%
EBITDA Margin 16.32% 5.62%
47.48% 65.56%
Net Margin 5.39% 1.51%
36.31% 71.99%

1 Analyst has issued a sales forecast Geratherm Medical 2024 . The average Geratherm Medical sales estimate is

€17.8m
Unlock
. This is
0.17% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€17.8m 0.17%
Unlock
, the lowest is
€17.8m 0.17%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €21.0m 18.92%
2024
€17.8m 15.08%
Unlock
2025
€18.0m 1.12%
Unlock
2026
€19.1m 6.11%
Unlock
2027
€20.5m 7.33%
Unlock

1 Analyst has issued an EBITDA forecast Geratherm Medical 2024 . The average Geratherm Medical EBITDA estimate is

€1.0m
Unlock
. This is
50.50% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€1.0m 50.50%
Unlock
, the lowest is
€1.0m 50.50%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €3.4m 19.58%
2024
€1.0m 70.76%
Unlock
2025
€2.7m 170.00%
Unlock
2026
€3.1m 14.81%
Unlock
2027
€3.3m 6.45%
Unlock
2028
€3.5m 6.06%
Unlock

EBITDA Margin

2023 16.32% 47.48%
2024
5.62% 65.56%
Unlock
2025
15.00% 166.90%
Unlock
2026
16.23% 8.20%
Unlock
2027
16.10% 0.80%
Unlock

1 Analyst has issued a net profit forecast Geratherm Medical 2024 . The average Geratherm Medical net profit estimate is

€270k
Unlock
. This is
133.46% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€270k 133.46%
Unlock
, the lowest is
€270k 133.46%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €1.1m 10.53%
2024
€270k 76.10%
Unlock
2025
€160k 40.74%
Unlock
2026
€480k 200.00%
Unlock
2027
€910k 89.58%
Unlock

Net Margin

2023 5.39% 36.31%
2024
1.51% 71.99%
Unlock
2025
0.90% 40.40%
Unlock
2026
2.54% 182.22%
Unlock
2027
4.46% 75.59%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share 0.21 0.05
10.53% 76.19%
P/E 61.20
EV/Sales 0.96

1 Analysts have issued a Geratherm Medical forecast for earnings per share. The average Geratherm Medical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€0.05
Unlock
. This is
133.33% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€0.05 133.33%
Unlock
, the lowest is
€0.05 133.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €0.21 10.53%
2024
€0.05 76.19%
Unlock
2025
€0.03 40.00%
Unlock
2026
€0.09 200.00%
Unlock
2027
€0.17 88.89%
Unlock

P/E ratio

Current -19.81 94.07%
2024
61.20 408.93%
Unlock
2025
102.00 66.67%
Unlock
2026
34.00 66.67%
Unlock
2027
18.00 47.06%
Unlock

Based on analysts' sales estimates for 2024, the Geratherm Medical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.95 17.39%
2024
0.96 0.54%
Unlock
2025
0.94 1.12%
Unlock
2026
0.89 5.75%
Unlock
2027
0.83 6.83%
Unlock

P/S ratio

Current 0.93 25.31%
2024
0.93 0.16%
Unlock
2025
0.92 1.11%
Unlock
2026
0.87 5.76%
Unlock
2027
0.81 6.83%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today